Asia-Pacific Drug Delivery Market – Industry Trends and Forecast to 2027

  • Healthcare IT
  • Upcoming Report
  • Jun 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Drug Delivery Market, By Product Type (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End User (Hospitals, Ambulatory Surgical Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Direct Tenders, Online Pharmacy), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market

Market Analysis and Insights : Asia-Pacific Drug Delivery Market

Drug delivery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 510.62 billion by 2027 growing at a CAGR of 12.40% in the above-mentioned forecast period. The growing demand for effective delivery technique in the biopharmaceuticals and the improvement in the safety and ability of a drug to control the drug release in the body are some of the factors which are influencing the growth in the market.

The growing cases and presence of chronic diseases is likely to accelerate the growth of the Drug delivery market in the forecast period of 2020-2027. On the other hand, launch of advanced new products and advancement in technologies will further boost various opportunities in the growth of the Drug delivery market in the above mentioned forecast period.

The product recalling and side effect associated with drugs is likely to hamper the growth of the drug delivery market in the above mentioned forecast period.

This drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Drug Delivery Market Scope and Market Size

Drug delivery market is segmented on the basis of product type, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, ocular drug delivery, nasal drug delivery, topical drug delivery implantable drug delivery and transmucosal drug delivery. The oral drug delivery is segmented into solid oral drugs, liquid oral drugs and semi-solid oral drugs. The solid oral drugs are sub-segmented into tablets, capsules, powders and pills. The liquid oral drugs are sub-segmented into solutions and syrups. The semi-solid oral drugs are further sub-segmented into gels, emulsions and elixirs. The pulmonary drug delivery is segmented into formulations and devices. The devices are further sub-segmented into metered dose inhalers, dry powder inhalers and nebulizers. The nebulizers are sub-segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers. The injectable drug delivery is segmented into devices, self-injection devices and other injector devices. The conventional injection devices are sub-segmented into material, glass, plastic, product and usability. The product is segmented into fillable syringes and prefilled syringes. The usability is segmented into reusable syringes and disposable syringes. The self-injection devices are sub-segmented into needle-free injectors, auto injectors, pen injectors and wearable injectors. The formulations are divided into conventional drug delivery, novel drug delivery formulations and long-acting injection formulations. The ocular drug delivery is sub-segmented into formulations and ocular devices. The formulations are further sub-divided into liquid formulations and semi-solid formulations. The liquid formulations are divided into eye drops and liquid sprays. The semi-solid formulations consist of gels and eye ointments. The ocular devices consist of drug-coated contact lenses and ocular inserts. The nasal drug delivery is sub-segmented into nasal drops, nasal sprays, nasal powders and nasal gels. Under topical drug delivery it is segmented into formulations and devices (transdermal drug delivery). The formulations liquid is sub-segmented into topical drug delivery, semi-solid topical drug delivery and solid topical drug delivery. The liquid topical drug delivery is again sub-segmented into solutions and suspensions. The semi-solid topical drug delivery is sub-segmented into creams, gels, ointments, pastes and lotions. The solid topical drug delivery is segmented into suppositories and powders. The devices are sub-segmented into transdermal patches and transdermal gels. Implantable drug delivery is sub-segmented into active implantable drug delivery and passive implantable drug delivery. The transmucosal drug delivery is sub-segmented into oral transmucosal drug delivery and other transmucosal drug delivery. The oral transmucosal drug delivery is further sub-segmented into buccal drug delivery and sublingual drug delivery whereas the other transmucosal drug delivery is further sub-segmented into rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
  • On the basis of end user, the drug delivery market is segmented into hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers and other facilities of use.
  • Based on distribution channel, the drug delivery market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.

Drug Delivery Market Country Level Analysis

Drug delivery market is analysed and market size insights and trends are provided by country, product type, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific drug delivery market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and rest of Asia-Pacific (APAC).

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 with China emerging to be the leader due to growing funds allocated by the top companies in the field of R&D activities along with low prices of labour and clinical trials.

The country section of the drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug delivery market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Drug Delivery Market Share Analysis

Drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug delivery market.

The major players covered in the drug delivery market report are Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp., Bayer AG, Pfizer Inc, Novartis AG, 3M, BD, GlaxoSmithKline Plc, Sanofi and among other domestic players. Market share data is available for Asia-Pacific separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2016

TABLE 2 MOST EXPENSIVE DRUGS IN THE U.S. 

TABLE 3 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY MARKET, 2019-2020

TABLE 4 LIST OF FDA APPROVED GENERICS, IN 2019

TABLE 5 PATENT EXPIRY OF DRUGS, 2019

TABLE 6 ASIA PACIFIC DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2018-2027 (USD BILLION)

TABLE 7 ASIA PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 8 ASIA PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 9 ASIA PACIFIC SOLID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 10 ASIA PACIFIC LIQUID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 11 ASIA PACIFIC SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 12 ASIA PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 13 ASIA PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 14 ASIA PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 15 ASIA PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 16 ASIA PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 17 ASIA PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 18 ASIA PACIFIC SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 19 ASIA PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 20 ASIA PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 21 ASIA PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 22 ASIA PACIFIC OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 23 ASIA PACIFIC LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 24 ASIA PACIFIC SEMI SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 25 ASIA PACIFIC OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 26 ASIA PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 27 ASIA PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 28 ASIA PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 29 ASIA PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 30 ASIA PACIFIC TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 31 ASIA PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 32 ASIA PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 33 ASIA PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 34 ASIA PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 35 ASIA PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 36 ASIA PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 37 ASIA PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 38 ASIA PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 39 ASIA PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 40 ASIA PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 41 ASIA PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 42 ASIA PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 43 ASIA PACIFIC NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 44 ASIA PACIFIC DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 45 ASIA PACIFIC HOPITALS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 46 ASIA PACIFIC HOME HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 47 ASIA PACIFIC CLINICS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 48 ASIA PACIFIC COMMUNITY HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 49 ASIA PACIFIC OTHERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 50 ASIA PACIFIC DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 51 ASIA PACIFIC DIRECT TENDERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 52 ASIA PACIFIC HOSPITAL PHARMACIES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 53 ASIA PACIFIC PHARMACY STORES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 54 ASIA PACIFIC ONLINE PHARMACY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 55 ASIA-PACIFIC DRUG DELIVERY MARKET, BY COUNTRY, 2018-2027 (USD BILLION)

TABLE 56 ASIA-PACIFIC DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 57 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 58 ASIA-PACIFIC SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 59 ASIA-PACIFIC LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 60 ASIA-PACIFIC SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 61 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 62 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 63 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 64 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 65 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 66 ASIA-PACIFIC SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 67 ASIA-PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 68 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 69 ASIA-PACIFIC OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 70 ASIA-PACIFIC OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 71 ASIA-PACIFIC LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 72 ASIA-PACIFIC SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 73 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 74 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 75 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 76 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 77 ASIA-PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 78 ASIA-PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 79 ASIA-PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 80 ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 81 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 82 ASIA-PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 83 ASIA-PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 84 ASIA-PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 85 ASIA-PACIFIC NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 86 ASIA-PACIFIC DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 87 ASIA-PACIFIC DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 88 JAPAN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 89 JAPAN ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 90 JAPAN SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 91 JAPAN LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 92 JAPAN SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 93 JAPAN INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 94 JAPAN INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 95 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 96 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 97 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 98 JAPAN SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 99 JAPAN INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 100 JAPAN OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 101 JAPAN OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 102 JAPAN OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 103 JAPAN LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 104 JAPAN SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 105 JAPAN NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 106 JAPAN TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 107 JAPAN TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 108 JAPAN TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 109 JAPAN SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 110 JAPAN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 111 JAPAN SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 112 JAPAN IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 113 JAPAN TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 114 JAPAN ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 115 JAPAN OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 116 JAPAN PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 117 JAPAN NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 118 JAPAN DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 119 JAPAN DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 120 CHINA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 121 CHINA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 122 CHINA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 123 CHINA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 124 CHINA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 125 CHINA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 126 CHINA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 127 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 128 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 129 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 130 CHINA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 131 CHINA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 132 CHINA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 133 CHINA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 134 CHINA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 135 CHINA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 136 CHINA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 137 CHINA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 138 CHINA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 139 CHINA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 140 CHINA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 141 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 142 CHINA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 143 CHINA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 144 CHINA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 145 CHINA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 146 CHINA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 147 CHINA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 148 CHINA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 149 CHINA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 150 CHINA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 151 CHINA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 152 INDIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 153 INDIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 154 INDIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 155 INDIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 156 INDIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 157 INDIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 158 INDIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 159 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 160 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 161 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 162 INDIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 163 INDIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 164 INDIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 165 INDIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 166 INDIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 167 INDIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 168 INDIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 169 INDIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 170 INDIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 171 INDIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 172 INDIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 173 INDIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 174 INDIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 175 INDIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 176 INDIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 177 INDIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 178 INDIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 179 INDIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 180 INDIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 181 INDIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 182 INDIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 183 INDIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 184 SOUTH KOREA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 185 SOUTH KOREA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 186 SOUTH KOREA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 187 SOUTH KOREA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 188 SOUTH KOREA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 189 SOUTH KOREA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 190 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 191 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 192 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 193 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 194 SOUTH KOREA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 195 SOUTH KOREA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 196 SOUTH KOREA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 197 SOUTH KOREA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 198 SOUTH KOREA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 199 SOUTH KOREA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 200 SOUTH KOREA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 201 SOUTH KOREA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 202 SOUTH KOREA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 203 SOUTH KOREA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 204 SOUTH KOREA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 205 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 206 SOUTH KOREA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 207 SOUTH KOREA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 208 SOUTH KOREA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 209 SOUTH KOREA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 210 SOUTH KOREA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 211 SOUTH KOREA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 212 SOUTH KOREA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 213 SOUTH KOREA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 214 SOUTH KOREA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 215 SOUTH KOREA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 216 AUSTRALIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 217 AUSTRALIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 218 AUSTRALIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 219 AUSTRALIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 220 AUSTRALIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 221 AUSTRALIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 222 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 223 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 224 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 225 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 226 AUSTRALIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 227 AUSTRALIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 228 AUSTRALIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 229 AUSTRALIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 230 AUSTRALIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 231 AUSTRALIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 232 AUSTRALIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 233 AUSTRALIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 234 AUSTRALIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 235 AUSTRALIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 236 AUSTRALIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 237 AUSTRALIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 238 AUSTRALIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 239 AUSTRALIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 240 AUSTRALIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 241 AUSTRALIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 242 AUSTRALIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 243 AUSTRALIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 244 AUSTRALIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 245 AUSTRALIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 246 AUSTRALIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 247 AUSTRALIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 248 THAILAND DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 249 THAILAND ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 250 THAILAND SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 251 THAILAND LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 252 THAILAND SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 253 THAILAND INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 254 THAILAND INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 255 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 256 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 257 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 258 THAILAND SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 259 THAILAND INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 260 THAILAND OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 261 THAILAND OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 262 THAILAND OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 263 THAILAND LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 264 THAILAND SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 265 THAILAND NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 266 THAILAND TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 267 THAILAND TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 268 THAILAND TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 269 THAILAND SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 270 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 271 THAILAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 272 THAILAND IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 273 THAILAND TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 274 THAILAND ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 275 THAILAND OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 276 THAILAND PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 277 THAILAND NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 278 THAILAND DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 279 THAILAND DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 280 MALAYSIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 281 MALAYSIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 282 MALAYSIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 283 MALAYSIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 284 MALAYSIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 285 MALAYSIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 286 MALAYSIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 287 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 288 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 289 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 290 MALAYSIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 291 MALAYSIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 292 MALAYSIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 293 MALAYSIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 294 MALAYSIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 295 MALAYSIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 296 MALAYSIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 297 MALAYSIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 298 MALAYSIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 299 MALAYSIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 300 MALAYSIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 301 MALAYSIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 302 MALAYSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 303 MALAYSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 304 MALAYSIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 305 MALAYSIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 306 MALAYSIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 307 MALAYSIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 308 MALAYSIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 309 MALAYSIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 310 MALAYSIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 311 MALAYSIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 312 SINGAPORE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 313 SINGAPORE ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 314 SINGAPORE SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 315 SINGAPORE LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 316 SINGAPORE SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 317 SINGAPORE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 318 SINGAPORE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 319 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 320 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 321 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 322 SINGAPORE SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 323 SINGAPORE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 324 SINGAPORE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 325 SINGAPORE OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 326 SINGAPORE OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 327 SINGAPORE LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 328 SINGAPORE SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 329 SINGAPORE NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 330 SINGAPORE TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 331 SINGAPORE TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 332 SINGAPORE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 333 SINGAPORE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 334 SINGAPORE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 335 SINGAPORE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 336 SINGAPORE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 337 SINGAPORE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 338 SINGAPORE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 339 SINGAPORE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 340 SINGAPORE PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 341 SINGAPORE NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 342 SINGAPORE DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 343 SINGAPORE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 344 INDONESIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 345 INDONESIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 346 INDONESIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 347 INDONESIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 348 INDONESIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 349 INDONESIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 350 INDONESIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 351 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 352 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 353 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 354 INDONESIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 355 INDONESIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 356 INDONESIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 357 INDONESIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 358 INDONESIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 359 INDONESIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 360 INDONESIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 361 INDONESIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 362 INDONESIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 363 INDONESIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 364 INDONESIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 365 INDONESIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 366 INDONESIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 367 INDONESIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 368 INDONESIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 369 INDONESIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 370 INDONESIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 371 INDONESIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 372 INDONESIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 373 INDONESIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 374 INDONESIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 375 INDONESIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 376 PHILLIPINES DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 377 PHILLIPINES ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 378 PHILLIPINES SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 379 PHILLIPINES LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 380 PHILLIPINES SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 381 PHILLIPINES INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 382 PHILLIPINES INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 383 PHILLIPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 384 PHILLIPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 385 PHILLIPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 386 PHILLIPINES SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 387 PHILLIPINES INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 388 PHILLIPINES OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 389 PHILLIPINES OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 390 PHILLIPINES OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 391 PHILLIPINES LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 392 PHILLIPINES SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 393 PHILLIPINES NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 394 PHILLIPINES TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 395 PHILLIPINES TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 396 PHILLIPINES TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 397 PHILLIPINES SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 398 PHILLIPINES LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 399 PHILLIPINES SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 400 PHILLIPINES IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 401 PHILLIPINES TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 402 PHILLIPINES ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 403 PHILLIPINES OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 404 PHILLIPINES PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 405 PHILLIPINES NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 406 PHILLIPINES DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 407 PHILLIPINES DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 408 REST OF ASIA-PACIFIC DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

Browse Related Reports

Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

North America Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Drug Delivery Market – Industry Trends and Forecast to 2027

Global Topical Drug Delivery Market – Industry Trends - Forecast to 2026

North America Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Topical Drug Delivery Market – Industry Trends and Forecast to 2027

North America Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Trends and Forecast to 2027

Global Implantable Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary Drug Delivery Market - Industry Trends and Forecast to 2027

Global Oral Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary/Respiratory Drug Delivery Market – Industry Trends and Forecast to 2027

Global Nasal Drug Delivery Market – Industry Trends and Forecast to 2027

Global Needle-Free Drug Delivery Market – Industry Trends - Forecast to 2026

Global Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Asia-Pacific Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Europe Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Middle East - Africa Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

North America Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Global Inflammatory Disease Drug Delivery Market – Industry Trends & Forecast to 2026

Global Buccal Drug Delivery Market - Industry Trends and Forecast to 2026

U.S. Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Global Drug Delivery Market – Industry Trends and Forecast to 2027

Middle East and Africa Drug Delivery Market – Industry Trends and Forecast to 2027

Global Liposome Drug Delivery Market - Industry Trends and Forecast to 2027


Browse Related Blogs

Global Injectable drug delivery market is poised to reach USD 797.2 billion by 2022

Global Topical Drug Delivery Market is Expected to Reach an Estimated Value of USD 240.76 billion by 2026

North America Drug Delivery Market is poised to grow at 6.4% till 2024

Europe Drug Delivery Market is poised to grow at 7.3% from 2017 to 2024

Topical Drug Delivery Market to Grow at a CAGR of 9% in the Forecast Period of 2019 to 2026

Injectable Drug Delivery Market Rising at 12.4% CAGR Due to Surging Prevalence of Chronic Diseases

North America Injectable Drug Delivery Market is Poised to Grow at 11.0% to 2024

Asia-Pacific (APAC) Injectable Drug Delivery Market is Poised to Grow at 12.4% To 2024

Europe Injectable Drug Delivery Market Poised to Grow At 11.9% till 2024

Global Injectable Drug Delivery Market is Expected to Grow by CAGR 11.5% In The Forecast Period 2017 To 2024

North America Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

North America Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Nasal Drug Delivery Market to Witness High Demand Due to Rising Respiratory Problems

Increasing Prevalence of Skin Disease or Condition, Rising Aging Population, Growth in Topical Drug Delivery, Increasing Research and Development of New Dermatological Drugs are Expected to Drive the Global Rx Dermatology Topical Drug Delivery Market in the forecast period of 2019-2026

Oral Drug Delivery Market 2019: Size, Share, Scope, Growth Opportunities Analysis By AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, Novo Nordisk A/S. Johnson & Johnson Services, Inc. And Others

U.S. Rx Dermatology Topical Drug Delivery Market is Expected to grow at 4.9% in the Forecast Period of 2020 to 2027

Global Drug Delivery Market is Expected to grow at 8.0% in the Forecast Period of 2020 to 2027

Global Implantable Drug Delivery Market is Rising Exponentially at a CAGR of 8.0% in the Forecast Period

Global Pulmonary/Respiratory Drug Delivery Market is Rising Exponentially at a CAGR of 7.80%

Global Pulmonary Drug Delivery Market is Rising at a CAGR of 7.0% During the Anticipated Period of 2017 to 2024